Stocktoria
Viridian Therapeutics, Inc.DE VRDN
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-06-18
Viridian Therapeutics, Inc.DE institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 4,773,622 | $62.1M |
| CITADEL ADVISORS LLC | 2,382,934 | $46.6M |
| D. E. Shaw & Co., Inc. | 1,262,540 | $24.7M |
| Point72 Asset Management, L.P. | 322,836 | $6.3M |
| RENAISSANCE TECHNOLOGIES LLC | 203,100 | $4.0M |
| MILLENNIUM MANAGEMENT LLC | 140,595 | $2.8M |
| TWO SIGMA INVESTMENTS, LP | 35,114 | $686,830 |
| AQR CAPITAL MANAGEMENT LLC | 20,208 | $395,269 |
Source: SEC EDGAR filings · CIK 0001590750 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.